Imprivata, a healthcare-based digital identity company, and Keyo, a touchless technology business, have collaborated to introduce a new biometric patient identification solution.  

“Patients are expecting a safe and streamlined experience as they return to physical locations for medical care amidst the COVID-19 pandemic,” said Dr. Sean Kelly, Chief Medical Officer at Imprivata. “We’re pleased to help our customers meet those expectations with the touchless biometric identification, improved patient matching, and workflow optimization offered with the latest version of Imprivata PatientSecure.”

The Increasing Importance of Touchless Technology

With 45.5 million COVID-19 cases and 1.2 million deaths worldwide, the virus is here to stay and is easily contagious. Yet, society must also go on. This means that organizations need to find a way to live safely with COVID-19 and, along with masks and hand sanitizer, touchless technology is a major part of this adjustment.

Imprivata’s new technology is fulfilling this emerging need. The Next-Gen Palm scanner with touchless patient identification is secure, reliable and easy-to-use. 

“Imprivata PatientSecure offers a more secure and reliable form of biometric identification. Vein patterns are 100 times more accurate than fingerprints to identify people,” said Kelly. “The solution is also easy to use and more accessible because it doesn’t require a smartphone or any other personal device. A patient simply places his or her hand over the biometric scanner, which uses a harmless near-infrared light, and the advanced algorithm processes the patient’s vein pattern to create an encrypted and protected digital file which is linked to an individual’s unique medical records.”

Beyond preventing COVID-19 infections, Imprivata’s new technology is also expected to support healthcare organizations in a multitude of ways. Improving patient safety, reducing medical errors and protecting against fraud are just a couple examples of the impact Imprivata aims to have.

Future Plans for Imprivata

COVID-19 is here to stay, as is the increased need to take health precautions. This means a continued demand for safer technology, especially in the healthcare industry where the situation is most dangerous.

It seems that Imprivata and Keyo also intend to stay focused on bringing the next generation of biometric technology to healthcare.

“We are beyond excited to bring touchless biometric technology to the healthcare market with Imprivata,” said Jaxon Klein, Chief Executive Officer of Keyo. “We share an approach that leverages deep innovation to take on complex public health challenges nimbly and with unparalleled speed. Touchless patient identification delivers this kind of solution and value for healthcare right now, when it is needed most.”

ABOUT THE WRITER

Sarah Raza is a Tech Innovation Fellow with a background in computer science from Stanford. She is passionate about exploring the implications of increased usage of artificial intelligence and machine learning.